Also, Dernellis et al. demonstrated that treatment with atorvastatin (initiated at a minimum of 20 mg/day and increased to a maximum of 40 mg/day) lowered CRP levels coincidentally with reduced recurrence in patients with paroxysmal AF[28]. The gene discussed is CRP; the disease is Paroxysmal atrial fibrillation.